What Are The Odds Of Tesla Stock Declining To $150? — Negative

TSLA   Forbes — June 06, 2025

Tesla Inc. (NASDAQ: TSLA) dropped 14% in a single day yesterday, representing one of its most significant one-day falls in the past few years. The stock currently trades at around $285, significantly down from peaks exceeding $350 in 2024 — resulting in a loss of over $150 billion in market capitalization.

image for news What Are The Odds Of Tesla Stock Declining To $150?

Appointment of seasoned strategic industry executive strengthens the Board of Directors as Candel advances toward Biologics License Application submission and commercial development Appointment of seasoned strategic industry executive strengthens the Board of Directors as Candel advances toward Biologics License Application submission and commercial development

image for news Candel Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors

Interim two-year follow-up data from 42 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit at 24 months compared to baseline 83% of subjects maintained a clinically meaningful benefit with a 3 or more point improvement in Revised Venous Clinical Severity Score (rVCSS) 9.1 point average rVCSS improvement among the clinically meaningful benefit cohort Subjects experienced a median 74% improvement in leg pain Interim follow-up data indicate sustained improvements across all venous-specific quality-of-life (QoL) indicators A decision from the U.S. Food and Drug Administration (FDA) on the VenoValve is anticipated in the second half of …

image for news Positive Interim 2-Year Data from enVVeno Medical's VenoValve Pivotal Study to be Presented Today at the Society for Vascular Surgery (SVS) 2025 Vascular Annual Meeting

Gold News: Fed Rate Cut Bets Rise—Will Weak Payrolls Spark a Gold Rally? — Neutral

AAAU  BAR  DBP  DGL  GLD  GLDM  IAU  OUNZ  SGOL  UGL   FXEmpire — June 06, 2025

Gold prices hold above key support as traders await NFP data. A weak report could boost Fed cut bets and trigger a gold rally toward $3435 and beyond.

image for news Gold News: Fed Rate Cut Bets Rise—Will Weak Payrolls Spark a Gold Rally?

COCONUT CREEK, Fla., June 06, 2025 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” or the “Company”), the leading lessor of commercial aircraft engines and global provider of aviation services, announced today that its wholly-owned subsidiary, Willis Engine Structured Trust VIII (“WEST”), has priced $524,000,000 in aggregate principal amount of Series A Fixed Rate Notes (the “Series A Notes”) and $72,000,000 in aggregate principal amount of Series B Fixed Rate Notes (the “Series B Notes” and, together with the Series A Notes, the “Notes”). The Notes will be secured by, among other things, WEST's direct and indirect interests …

image for news Willis Lease Finance Corporation Announces Pricing of $596.0 Million in Fixed Rate Notes

Douglas Dynamics Declares Quarterly Cash Dividend — Neutral

PLOW   GlobeNewsWire — June 06, 2025

MILWAUKEE, June 06, 2025 (GLOBE NEWSWIRE) -- Douglas Dynamics, Inc. (NYSE: PLOW), North America's premier manufacturer and upfitter of work truck attachments and equipment, today announced that its Board of Directors approved and declared a quarterly cash dividend of $0.295 per share for the second quarter of 2025.

image for news Douglas Dynamics Declares Quarterly Cash Dividend

HAMPTON, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that Denice M. Torres has been elected to the company's Board of Directors.

image for news Celldex Therapeutics Announces Election of Denice Torres to its Board of Directors

Nantahala Capital Management, Stonepine Capital Management, Aytu Management, and New Institutional Shareholders Lead Financing. DENVER, CO / ACCESS Newswire / June 6, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced the pricing of an upsized public offering of 9,600,000 shares of common stock (or prefunded warrants in lieu thereof) at an effective public offering price of $1.50.

image for news Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock

5 ETF Areas That Thrived Amid the Trump-Musk Feud Yesterday — Neutral

TSLA   Zacks Investment Research — June 06, 2025

TSLA tumbled 14.3% on June 5 as a public clash between Trump and Elon Musk rattled markets and boosted ETFs like TSLZ, SMCZ, AGQ, KORU and MULL on Jun 5.

image for news 5 ETF Areas That Thrived Amid the Trump-Musk Feud Yesterday

Bear Of The Day: First Solar (FSLR) — Negative

FSLR   Zacks Investment Research — June 06, 2025

This stock has seen negative earnings estimate revisions for this year and next.

image for news Bear Of The Day: First Solar (FSLR)

How High Can Netflix Stock Climb? It's Just Getting Started — Positive

NFLX   Forbes — June 06, 2025

Streaming giant Netflix (NFLX) has built a 3.5% lead this week alone, thanks to price-target hikes from UBS to $1,450 on Wednesday, and from Jefferies to $1,400 on Tuesday. Out of the gate on Thursday, the shares hit a record high of $1,262.81, bringing its year-to-date tally up to 40%.

image for news How High Can Netflix Stock Climb? It's Just Getting Started

DALLAS, June 06, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on June 2, 2025, the Compensation Committee of Taysha's Board of Directors granted two new employees, in the aggregate, options to purchase 401,000 shares of the Company's common stock in connection with their employment. The stock options were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with …

image for news Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Talkspace to Participate in Upcoming Investor Conferences — Neutral

TALK   GlobeNewsWire — June 06, 2025

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Talkspace (Nasdaq: TALK), a leading behavioral healthcare company, today announced that members of senior management will participate in the following upcoming investor conferences:

image for news Talkspace to Participate in Upcoming Investor Conferences

BETHESDA, Md.--(BUSINESS WIRE)--RLJ Lodging Trust (the “Company”) (NYSE: RLJ) today announced it will report financial results for the second quarter ended June 30, 2025, after the markets close on August 7, 2025. The Company will also host a conference call on August 8, 2025, at 10:00 a.m. (Eastern Time). The Company recommends that you dial in approximately 10 minutes before the call. The conference call can be accessed by dialing (877) 407-3982 or (201) 493-6780 for international participant.

image for news RLJ Lodging Trust Announces Second Quarter 2025 Earnings Release and Conference Call Dates

PATRIOTISM MEETS HORSEPOWER: ANDY ROSS TO IGNITE BRISTOL DRAGWAY WITH ELECTRIFYING PERFORMANCE! NASHVILLE, TN, June 06, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) ("American Rebel" or the "Company"), creator of American Rebel Beer (americanrebelbeer.com) and a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel (americanrebel.com), is excited to report that American Rebel CEO Andy Ross will perform at the Super Grip NHRA Thunder Valley Nationals Saturday, June 7, on the Midway Stage from 1:45 to 2:45 pm.

image for news American Rebel CEO to Perform at Bristol Dragway and American Rebel Light Beer to be Featured at Trackside Bar and Beer Garden

BOISE, Idaho--(BUSINESS WIRE)-- #BuiltOnRelationships--KB Home (NYSE: KBH), one of the largest and most trusted homebuilders in the U.S., today announced the grand opening of Pivot Pointe, a new community in desirable Meridian, Idaho. The new homes are designed for the way people live today, with popular features like modern kitchens overlooking large great rooms, bedroom suites with walk-in closets, and ample storage space. Pivot Pointe's two-story floor plans feature up to five bedrooms and three baths. Homeowners w.

image for news KB Home Announces the Grand Opening of Its Newest Community in a Prime Meridian, Idaho Location

FORT PIERCE, FL / ACCESS Newswire / June 6, 2025 / Twin Vee PowerCats Co. (Nasdaq:VEEE),("Twin Vee" or the "Company"), a manufacturer, distributor, and marketer of power sport boats, proudly announces the acquisition of Bahama Boat Works, uniting two renowned legacies in the marine industry. The iconic Bahama brand, long celebrated for its unmatched craftsmanship, timeless aesthetic, and dedication to producing some of the finest offshore fishing vessels, will continue to uphold these standards under Twin Vee.

image for news Twin Vee PowerCats Co. Announces Acquisition of Iconic Bahama Boat Works

Aytu enters the over $22 billion United States prescription major depressive disorder ("MDD") market with the first-in-class oral selective serotonin 5HT1a receptor agonist for adults with MDD. EXXUA has demonstrated significant improvement in depression symptoms in clinical trials involving more than 5,000 patients and, notably, the incidence of sexual side effects experienced with EXXUA was comparable to placebo.

image for news Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States

BOCA RATON, FL, June 06, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company” or “DeFi Dev Corp.”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced a strategic partnership with Drift Protocol, the leading decentralized derivatives exchange on Solana with $1B in deposits.

image for news DeFi Dev Corp. Partners with Drift Protocol to List dfdvSOL Liquid Staking Token

BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present four posters at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress, taking place June 13-16, 2025 in Glasgow, United Kingdom. Dr. William Yang, M.D., FRCPC, FAAAAI, Managing Director and Chair, Ottawa Allergy Research Corporation, will present combined i.

image for news Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Annual Congress